PhotonPharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy in Recurrent Epithelial Ovarian Cancer
Phase 1
Not yet recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Biological: Innocell Autologous Cellular Immunotherapy
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- PhotonPharma, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06366490
© Copyright 2025. All Rights Reserved by MedPath